Latest Insider Transactions at Boston Scientific Corp (BSX)
This section provides a real-time view of insider transactions for Boston Scientific Corp (BSX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BOSTON SCIENTIFIC CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BOSTON SCIENTIFIC CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
7,500
-5.36%
|
$285,000
$38.0 P/Share
|
|
May 16
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Bona fide gift
|
Direct |
26
-0.02%
|
-
|
|
May 16
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
7,500
-5.09%
|
$292,500
$39.43 P/Share
|
|
May 05
2022
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,877
+22.21%
|
-
|
|
May 05
2022
|
Nelda J Connors Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,877
+23.4%
|
-
|
|
May 05
2022
|
Edward J Ludwig Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,877
+10.54%
|
-
|
|
May 05
2022
|
David J Roux Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,877
+6.54%
|
-
|
|
May 05
2022
|
John E Sununu Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,877
+9.62%
|
-
|
|
May 05
2022
|
David S Wichmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,613
+10.89%
|
-
|
|
May 05
2022
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,877
+10.47%
|
-
|
|
May 01
2022
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
606
-2.42%
|
$25,452
$42.11 P/Share
|
|
May 01
2022
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
2,062
+7.6%
|
-
|
|
Apr 20
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
9,645
-8.04%
|
$443,670
$46.5 P/Share
|
|
Apr 19
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
10,989
-8.39%
|
$494,505
$45.5 P/Share
|
|
Apr 14
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
7,500
-4.84%
|
$330,000
$44.47 P/Share
|
|
Apr 01
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Open market or private sale
|
Direct |
2,779
-10.67%
|
$125,055
$45.0 P/Share
|
|
Apr 01
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Open market or private sale
|
Direct |
700
-4.6%
|
$30,800
$44.55 P/Share
|
|
Mar 29
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
10,269
-25.33%
|
$462,105
$45.0 P/Share
|
|
Mar 29
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
5,411
+11.77%
|
$86,576
$16.31 P/Share
|
|
Mar 28
2022
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Open market or private sale
|
Direct |
6,588
-19.0%
|
$283,284
$43.68 P/Share
|
|
Mar 22
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
11,236
-7.9%
|
$494,384
$44.5 P/Share
|
|
Mar 15
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
7,500
-4.62%
|
$315,000
$42.34 P/Share
|
|
Mar 03
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,779
-0.81%
|
$76,497
$43.96 P/Share
|
|
Mar 03
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,603
+1.61%
|
-
|
|
Mar 02
2022
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
11,029
-4.01%
|
$485,276
$44.03 P/Share
|
|
Mar 01
2022
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
1,726
-100.0%
|
$74,218
$43.94 P/Share
|
|
Feb 28
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
640
-1.79%
|
$28,160
$44.17 P/Share
|
|
Feb 28
2022
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,528
+4.1%
|
-
|
|
Feb 28
2022
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,988
-0.72%
|
$87,472
$44.17 P/Share
|
|
Feb 28
2022
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,481
+1.59%
|
-
|
|
Feb 28
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
479
-0.29%
|
$21,076
$44.17 P/Share
|
|
Feb 28
2022
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,630
+0.99%
|
-
|
|
Feb 28
2022
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-0.91%
|
$13,200
$44.17 P/Share
|
|
Feb 28
2022
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,019
+2.99%
|
-
|
|
Feb 28
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
419
-1.58%
|
$18,436
$44.17 P/Share
|
|
Feb 28
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,426
+5.11%
|
-
|
|
Feb 28
2022
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084
-2.01%
|
$47,696
$44.17 P/Share
|
|
Feb 28
2022
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,444
+4.33%
|
-
|
|
Feb 28
2022
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-0.86%
|
$13,200
$44.17 P/Share
|
|
Feb 28
2022
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,019
+2.83%
|
-
|
|
Feb 28
2022
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,130
-0.38%
|
$357,720
$44.17 P/Share
|
|
Feb 28
2022
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,330
+0.85%
|
-
|
|
Feb 28
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
624
-0.44%
|
$27,456
$44.17 P/Share
|
|
Feb 28
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,037
+1.41%
|
-
|
|
Feb 28
2022
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
238
-0.75%
|
$10,472
$44.17 P/Share
|
|
Feb 28
2022
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
815
+2.52%
|
-
|
|
Feb 28
2022
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
564
-0.32%
|
$24,816
$44.17 P/Share
|
|
Feb 28
2022
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Exercise of conversion of derivative security
|
Direct |
1,630
+0.91%
|
-
|
|
Feb 28
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
766
-4.79%
|
$33,704
$44.17 P/Share
|
|
Feb 28
2022
|
Scott Olson SVP & Pres, CRM, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,426
+8.19%
|
-
|